Home » Topics » BioWorld Science

BioWorld Science
RSS

City of Hope National Medical Center divulges new CARs for treating T-cell lymphoma

Dec. 22, 2020

Aligos Therapeutics presents HBV and HDV antivirals

Dec. 22, 2020

Celgene synthesizes new CKI-alpha degradation inducers

Dec. 22, 2020

Pfizer/BioNTech COVID-19 vaccine receives conditional marketing authorization in Europe

Dec. 22, 2020

Sage Therapeutics has patented GABA(A) receptor modulators

Dec. 22, 2020

Enanta Pharmaceuticals divulges compounds for HBV infection

Dec. 22, 2020

Fintepla approved in Europe for the treatment of seizures in Dravet syndrome

Dec. 22, 2020

Initiation of phase I study evaluating MB-101 in patients with leptomeningeal brain tumors

Dec. 22, 2020

ImmuneMed progresses hzVSF-v13 into phase II clinical development in various countries

Dec. 22, 2020

BI-767551 enters phase I/IIa development

Dec. 22, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...